Steno Diabetes Center Copenhagen: Diabetic Nephropathies trials
The registry lists 10 Diabetic Nephropathies studies with Steno Diabetes Center Copenhagen as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1Phase 4 5No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxiaNot yet recruitingNCT06147232Phase 2
- Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 DiabetesCompletedNCT04635670Not applicable
- Kidney Fat in Type 2 Diabetes and the Effects of EzetimibeStatus unknownNCT04589351Phase 3
- Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and AlbuminuriaStatus unknownNCT04061200Phase 4
- Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)WithdrawnNCT03504566Phase 4
- Antiproteinuric Effects of Liraglutide TreatmentCompletedNCT02545738Phase 4
- Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic NephropathyCompletedNCT01521910Not applicable
- Spironolactone in Diabetic NephropathyCompletedNCT00317954Phase 4
- Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic NephropathyCompletedNCT00311870Phase 4
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney DiseaseCompletedNCT00118976Not applicable